小脑幕硬脑膜动静脉瘘的血管内治疗:一项回顾性单中心研究
回顾性分析2009年4月至2023年11月单中心83例以小脑幕硬脑膜动静脉瘘为首选治疗接受血管内治疗的患者,末次治疗后即刻完全闭塞率89.1%,6个月造影随访闭塞率91.2%,临床随访良好功能结局(mRS 0-2)占89.1%,并发症发生率13.3%;基线mRS 3-5是功能结局不良的最显著独立预测因素;在存在软脑膜动脉供血的患者中,省略积极栓塞未影响疗效或增加并发症。
要点
- 小脑幕硬脑膜动静脉瘘血管内治疗末次术后即刻完全闭塞率89.1%(74/83)。
- 6个月造影随访68例中91.2%(62/68)瘘口闭塞,临床随访83例中89.1%达mRS 0-2。
- 基线mRS 3-5是功能结局不良的最显著独立预测因素。
核心结论
- 血管内治疗是小脑幕硬脑膜动静脉瘘安全有效的首选技术,可实现高比例完全造影闭塞和良好功能结局;经动脉栓塞(主要经脑膜中动脉)是主要治疗方式;对于存在软脑膜动脉供血的患者,省略积极栓塞未影响疗效或增加并发症。
研究设计与样本
- 回顾性单中心研究,纳入2009年4月至2023年11月本中心83例以小脑幕硬脑膜动静脉瘘为首选治疗接受血管内治疗的患者;采集人口学、临床表现、血管造影、治疗结果和随访结局;采用单因素和多因素logistic回归分析颅内出血发生、操作相关并发症及功能结局不良的预测因素。
诊断标准与关键数值
- 末次血管内治疗后即刻完全闭塞74/83(89.1%)。
- 6个月造影随访68/83(81.8%)中,完全闭塞62/68(91.2%)。
- 临床随访83/83(100%),良好功能结局(mRS 0-2)74例(89.1%)。
- 并发症发生11例(13.3%)。
- 基线mRS 3-5是功能结局不良的最显著独立预测因素。
临床应用与阅片要点
- 经动脉栓塞是主要治疗途径,最常用入路为脑膜中动脉(57.8%,48/83)和软脑膜动脉(15.7%,13/83)。
- 存在软脑膜动脉供血者中,靶向软脑膜动脉栓塞与非靶向软脑膜动脉栓塞两组在基线特征、造影和临床结果上无统计学显著差异。
- 深静脉引流和中线位置与较低的颅内出血发生率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Current evidence suggests that tentorial dural arteriovenous fistulas with endovascular treatment offer a high rate of occlusion and reduced procedural risks. We report the clinical and angiographic outcomes in patients with tentorial dural arteriovenous fistulas who underwent endovascular treatment as first-line treatment.
MATERIALS AND METHODS: A retrospective analysis was conducted on 83 patients with tentorial dural arteriovenous fistulas treated at our center from April 2009 to November 2023 by using endovascular treatment. Patient demographics, clinical presentations, angiographics, treatment results, and follow-up outcomes were registered. Univariable and multivariable logistic regression were performed to identify the onset of intracranial hemorrhage predictors, procedure-related complications predictors, and predictors of poor functional outcome.
RESULTS: Eighty-three patients underwent endovascular treatment as first-line treatment. Most patients (80.7%) were symptomatic, and a total of 25 patients (30.1%) presented with intracranial hemorrhage. The presence of deep venous drainage and midline location were associated with a lower incidence of intracranial hemorrhage. Middle meningeal artery (57.8%, 48/83) and pial artery (15.7%, 13/83) were the most frequently used access routes for embolization. A total of 74 (89.1%) tentorial dural arteriovenous fistulas were completely occluded immediately after the last endovascular treatment session. Complications occurred in 11 patients (13.3%). Six-month angiographic follow-up was performed in 68 patients (81.8%), and 91.2% (62/68) of tentorial dural arteriovenous fistulas were occluded. At clinical follow-up (100%, 83/83), good functional outcome (mRS 0-2) was documented in 74 (89.1%) patients. Logistic regression analysis identified baseline mRS 3-5 as the most significant independent predictor of poor functional outcome. Subgroup analysis showed no statistically significant differences in baseline characteristics, angiography, and clinical results between patients treated with targeted pial artery embolization and nontargeted pial artery embolization.
CONCLUSIONS: Endovascular treatment is a safe and effective primary technique for managing tentorial dural arteriovenous fistulas, achieving high rates of complete angiographic occlusion and favorable functional outcomes. Transarterial embolization, predominantly via the middle meningeal artery, was the mainstay of treatment. In patients with pial arterial feeders, omitting aggressive embolization did not compromise efficacy or increase complications.
引用
- Zhang G, Pang M, Li Z, et al. Endovascular Treatment for Tentorial Dural Arteriovenous Fistulas: A Retrospective Single-Center Study. AJNR Am J Neuroradiol. 2025. PMID: 39880688. doi:10.3174/ajnr.A8676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。